Your browser doesn't support javascript.
loading
TcpC inhibits toll-like receptor signaling pathway by serving as an E3 ubiquitin ligase that promotes degradation of myeloid differentiation factor 88.
Fang, Jia-Qi; Ou, Qian; Pan, Jun; Fang, Jie; Zhang, Da-Yong; Qiu, Miao-Qi; Li, Yue-Qi; Wang, Xiao-Hui; Yang, Xue-Yu; Chi, Zhe; Gao, Wei; Guo, Jun-Ping; Miethke, Thomas; Pan, Jian-Ping.
Affiliation
  • Fang JQ; Institute of Translational Medicine, Zhejiang University City College, Hangzhou, Peoples Republic of China.
  • Ou Q; Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, Peoples Republic of China.
  • Pan J; Institute of Translational Medicine, Zhejiang University City College, Hangzhou, Peoples Republic of China.
  • Fang J; Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, Peoples Republic of China.
  • Zhang DY; Cancer Institute, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Peoples Republic of China.
  • Qiu MQ; Institute of Translational Medicine, Zhejiang University City College, Hangzhou, Peoples Republic of China.
  • Li YQ; Department of Clinical Medicine, Zhejiang University City College School of Medicine, Hangzhou, Peoples Republic of China.
  • Wang XH; Institute of Translational Medicine, Zhejiang University City College, Hangzhou, Peoples Republic of China.
  • Yang XY; Department of Clinical Medicine, Zhejiang University City College School of Medicine, Hangzhou, Peoples Republic of China.
  • Chi Z; Department of Clinical Medicine, Zhejiang University City College School of Medicine, Hangzhou, Peoples Republic of China.
  • Gao W; Department of Clinical Medicine, Zhejiang University City College School of Medicine, Hangzhou, Peoples Republic of China.
  • Guo JP; Department of Clinical Medicine, Zhejiang University City College School of Medicine, Hangzhou, Peoples Republic of China.
  • Miethke T; Department of Clinical Medicine, Zhejiang University City College School of Medicine, Hangzhou, Peoples Republic of China.
  • Pan JP; Institute of Translational Medicine, Zhejiang University City College, Hangzhou, Peoples Republic of China.
PLoS Pathog ; 17(3): e1009481, 2021 03.
Article in En | MEDLINE | ID: mdl-33788895
ABSTRACT
TcpC is a virulence factor of uropathogenic E. coli (UPEC). It was found that TIR domain of TcpC impedes TLR signaling by direct association with MyD88. It has been a long-standing question whether bacterial pathogens have evolved a mechanism to manipulate MyD88 degradation by ubiquitin-proteasome pathway. Here, we show that TcpC is a MyD88-targeted E3 ubiquitin ligase. Kidney macrophages from mice with pyelonephritis induced by TcpC-secreting UPEC showed significantly decreased MyD88 protein levels. Recombinant TcpC (rTcpC) dose-dependently inhibited protein but not mRNA levels of MyD88 in macrophages. Moreover, rTcpC significantly promoted MyD88 ubiquitination and accumulation in proteasomes in macrophages. Cys12 and Trp106 in TcpC are crucial amino acids in maintaining its E3 activity. Therefore, TcpC blocks TLR signaling pathway by degradation of MyD88 through ubiquitin-proteasome system. Our findings provide not only a novel biochemical mechanism underlying TcpC-medicated immune evasion, but also the first example that bacterial pathogens inhibit MyD88-mediated signaling pathway by virulence factors that function as E3 ubiquitin ligase.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Escherichia coli Proteins / Virulence Factors / Myeloid Differentiation Factor 88 / Uropathogenic Escherichia coli Limits: Animals / Female / Humans Language: En Journal: PLoS Pathog Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Escherichia coli Proteins / Virulence Factors / Myeloid Differentiation Factor 88 / Uropathogenic Escherichia coli Limits: Animals / Female / Humans Language: En Journal: PLoS Pathog Year: 2021 Document type: Article